Masimo (MASI) Gets CE Mark for Respiration Sensor RAS-45

Masimo Corporation MASI recently announced the receipt of CE mark for RAS-45, a single use adhesive respiration sensor for ‘rainbow acoustic monitoring' of respiration rate. This approval is expected to strengthen the company's foothold in growing respiratory care market in Europe.

Notably, rainbow acoustic monitoring or RAM is a flagship noninvasive technology of Masimo that continuously measures respiration rate of the prospective patients using an adhesive sensor and an acoustic transducer.

RAS-45 exclusively operates for post-surgical patients undergoing patient-controlled analgesia (self administered pain management). Here we note that RAS-45 and RAS 125-c are two notable adhesive sensors in RAM.

As per management, the RAS-45 go-ahead highlights the exclusivity of the product (smaller adhesive profile, usage of transparent adhesive and flexibility) compared to the likes that are presently available in the market. The product is also likely to empower the company's flagship signal extraction (SET), rainbow and the MX technologies.

MASIMO CORP Price

 

MASIMO CORP Price | MASIMO CORP Quote

Our Take

We believe that the latest development will significantly fortify the company's product portfolio of adhesive sensors and thus help the company tap into the abundant opportunities in Europe. Meanwhile, Masimo's SET pulse oximetry business already represents considerable growth opportunities in international markets.

Even the global market trends seem to be quite lucrative as an analysis by the Markets And Markets reveal that the respiratory-care devices market is forecasted to grow at a CAGR of 9.6% to $21.9 billion by 2020. Buoyed by this trend, we presume Masimo with its series of latest product developments, will significantly gain traction in the respiratory care and related ancillary markets .

Lately shares of Masimo have been on the rise with a strong one-year return of 38.8%, much better than the S&P 500's 7.4% over the same period. We believe, the CE mark for RAS-45 will help the company maintain the trend.

Zacks Rank & Other Key Picks

Currently, Masimo has a Zacks Rank #1 (Strong Buy).

Other favorably ranked stocks in the broader medical sector include CryoLife Inc. CRY, Natus Medical BABY and NuVasive Inc. NUVA. Notably, all the three stocks sport the same Zacks Rank as Masimo.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>